Diagnosis: Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)
This patient most likely has bisphosphonate-related osteonecrosis of the jaw (BRONJ), given the unilateral mandibular swelling, missing teeth, exposed bone (suggested by the linear white lines), and absence of pain—all classic features of this condition.
Clinical Reasoning
The presentation is highly characteristic of BRONJ:
- Unilateral mandibular swelling with missing lower left jaw teeth
- Linear white lines in the mouth (likely exposed necrotic bone)
- Painless (typical of BRONJ, unlike dental infections)
- Bow leg deformity suggests prior bisphosphonate use for metabolic bone disease (Paget's disease, osteoporosis, or other bone disorder)
- Mild pedal edema may indicate renal impairment from bisphosphonate toxicity or underlying systemic disease
The bow legs are a critical clue—this deformity suggests long-standing metabolic bone disease that was likely treated with bisphosphonates. The essentially normal labs (calcium 8.9, albumin 4.3) argue against active hyperparathyroidism or malignancy-related bone disease.
Immediate Management Algorithm
1. Confirm Bisphosphonate Exposure
- Obtain detailed medication history, specifically asking about:
- Oral bisphosphonates (alendronate, risedronate) for osteoporosis
- IV bisphosphonates (zoledronic acid, pamidronate) for Paget's disease or bone metastases
- Duration and cumulative dose of exposure
2. Stage the ONJ
Perform imaging (panoramic radiograph or cone-beam CT) to assess extent of bone involvement and stage according to AAOMS criteria.
3. Conservative Management (First-Line)
Discontinue bisphosphonates immediately 1, 2, 3, 1, 4, 3
Antimicrobial mouth rinse:
Systemic antibiotics if infection present:
- Amoxicillin 500 mg three times daily for 10-14 days, OR
- If penicillin-allergic: Clindamycin 300 mg four times daily 4
Pain management:
- Acetaminophen 650-1000 mg every 6 hours as needed
- Avoid NSAIDs if renal function is compromised
4. Dental Consultation
Immediate referral to oral maxillofacial surgery for:
- Debridement of necrotic bone if conservative measures fail
- Avoid invasive dental procedures until ONJ resolves 1, 4
5. Monitor Renal Function
Check serum creatinine—bisphosphonates cause nephrotoxicity, and the mild pedal edema raises concern 1, 2, 3, 1
Critical Pitfalls to Avoid
Do NOT:
- Resume bisphosphonates while ONJ is active
- Perform dental extractions or implants without resolving ONJ first 1, 4
- Assume this is a simple dental infection—the painless nature and exposed bone are pathognomonic for BRONJ
Do NOT miss:
- Underlying malignancy (breast cancer, multiple myeloma) if bisphosphonate history is unclear—these patients receive higher doses and have 9.5-fold higher ONJ risk with zoledronic acid versus pamidronate 2, 3
- Renal dysfunction requiring dose adjustment or discontinuation 1, 2, 3
Alternative Diagnoses to Consider
If bisphosphonate exposure is absent, consider:
- Fibrous dysplasia (unilateral mandibular swelling, ground-glass appearance on imaging) 5, 6
- Brown tumor from hyperparathyroidism (but calcium is normal at 8.9) 7
- Central giant cell granuloma (rare in posterior mandible at this age) 8
- IgG4-related disease (but typically presents with gingival enlargement and periodontitis) 9
Prognosis and Follow-Up
Conservative management resolves stage 1-2 ONJ in most cases. Stage 3 ONJ (with pathologic fracture, extraoral fistula, or extensive bone necrosis) requires surgical debridement and resection 4. The absolute risk of ONJ in osteoporosis patients on long-term oral bisphosphonates (>4 years) is 0.21%, but increases to 0.5% after tooth extraction 4.
Follow-up schedule: